200 related articles for article (PubMed ID: 38240197)
1. High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.
Zhou XD; Chen QF; Targher G; Byrne CD; Shapiro MD; Tian N; Xiao T; Sung KC; Lip GYH; Zheng MH
J Am Heart Assoc; 2024 Feb; 13(3):e032997. PubMed ID: 38240197
[TBL] [Abstract][Full Text] [Related]
2. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
3. Clonal Hematopoiesis and Incident Heart Failure With Preserved Ejection Fraction.
Schuermans A; Honigberg MC; Raffield LM; Yu B; Roberts MB; Kooperberg C; Desai P; Carson AP; Shah AM; Ballantyne CM; Bick AG; Natarajan P; Manson JE; Whitsel EA; Eaton CB; Reiner AP
JAMA Netw Open; 2024 Jan; 7(1):e2353244. PubMed ID: 38270950
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
[TBL] [Abstract][Full Text] [Related]
5. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
6. Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.
Williams D; Stout MJ; Rosenbloom JI; Olsen MA; Joynt Maddox KE; Deych E; Davila-Roman VG; Lindley KJ
J Am Coll Cardiol; 2021 Dec; 78(23):2281-2290. PubMed ID: 34857089
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population.
Chia YC; Kieneker LM; van Hassel G; Binnenmars SH; Nolte IM; van Zanden JJ; van der Meer P; Navis G; Voors AA; Bakker SJL; De Borst MH; Eisenga MF
J Am Heart Assoc; 2021 Jun; 10(11):e018549. PubMed ID: 33998283
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Vascular Resistance During Exercise Predicts Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction.
Huang W; Oliveira RKF; Lei H; Systrom DM; Waxman AB
J Card Fail; 2018 Mar; 24(3):169-176. PubMed ID: 29180305
[TBL] [Abstract][Full Text] [Related]
9. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
[TBL] [Abstract][Full Text] [Related]
10. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
[TBL] [Abstract][Full Text] [Related]
11. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.
Fudim M; Ambrosy AP; Sun JL; Anstrom KJ; Bart BA; Butler J; AbouEzzeddine O; Greene SJ; Mentz RJ; Redfield MM; Reddy YNV; Vaduganathan M; Braunwald E; Hernandez AF; Borlaug BA; Felker GM
J Am Heart Assoc; 2018 Dec; 7(24):e010364. PubMed ID: 30561266
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of high-sensitivity cardiac troponin in patients with heart failure with preserved ejection fraction.
Suzuki S; Motoki H; Minamisawa M; Okuma Y; Shoin W; Okano T; Kimura K; Ebisawa S; Okada A; Kuwahara K
Heart Vessels; 2019 Oct; 34(10):1650-1656. PubMed ID: 30929038
[TBL] [Abstract][Full Text] [Related]
13. Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study.
Hage C; Svedlund S; Saraste A; Faxén UL; Benson L; Fermer ML; Gan LM; Shah SJ; Lam CSP; Lund LH
J Card Fail; 2020 Nov; 26(11):1016-1021. PubMed ID: 32846205
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.
Sun LY; Tu JV; Bader Eddeen A; Liu PP
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
[TBL] [Abstract][Full Text] [Related]
16. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
Manolis AS; Manolis AA; Manolis TA; Melita H
Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
[TBL] [Abstract][Full Text] [Related]
17. Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60.
Nakagawa A; Yasumura Y; Yoshida C; Okumura T; Tateishi J; Yoshida J; Seo M; Yano M; Hayashi T; Nakagawa Y; Tamaki S; Yamada T; Kurakami H; Sotomi Y; Nakatani D; Hikoso S; Sakata Y;
J Am Heart Assoc; 2022 Aug; 11(15):e025300. PubMed ID: 35904209
[TBL] [Abstract][Full Text] [Related]
18. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
[TBL] [Abstract][Full Text] [Related]
19. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
